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Predictors of Neighborhood Risk for Late-Stage
Melanoma: Addressing Disparities through Spatial
Analysis and Area-Based Measures
Shasa Hu1,2, Recinda Sherman2,3, Kristopher Arheart3 and Robert S. Kirsner1,2,3
Minority populations have disproportionately more advanced stage melanoma and worse survival. To clarify the
impact of race and ethnicity on late-stage melanoma diagnosis, we performed spatial analysis of geocoded
melanoma cases diagnosed in Florida, 1999–2008, to identify geographic clusters of higher-than-expected
incidence of late-stage melanoma and developed predictive models for melanoma cases in high-risk neighbor-
hoods accounting for area-based poverty, race/ethnicity, patient insurance status, age, and gender. In the adjusted
model, Hispanic ethnicity and census tract-level poverty are the strongest predictors for clustering of late-stage
melanoma. Hispanic whites were 43% more likely to live in neighborhoods with excessive late-stage melanoma
(Po0.001) compared with non-Hispanic whites (NHW). For every 1% increase in population living in poverty,
there is a 2% increase in late-stage melanoma clustering (Po0.001). Census tract-level poverty predicted late-stage
melanoma similarly among NHW and Hispanic whites. The impact of insurance coverage varied among
populations; the most consistent trend was that Medicaid coverage is associated with higher odds for late-
stage melanoma. The finding that Hispanics are most likely to reside in high-risk neighborhoods, independent of
poverty and insurance status, underscores the importance of addressing, and overcoming community-level
barriers to melanoma care.
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INTRODUCTION
Melanoma remains among the top 10 cancer diagnoses for
American men and women with estimated 76,690 new cases
of invasive melanoma diagnosed in 2013 (American Cancer
Society, 2013). Public health efforts have led to earlier
detection of melanoma in whites (non-Hispanic whites or
NHW; Dennis, 1999; Hu et al., 2009), but Hispanics and
blacks still carry a significant burden of late-stage melanoma
(Hu et al., 2009; Wu et al., 2011), and have poorer survival
rates than NHW (Bellows et al., 2001; Wu et al., 2011), likely
due to delayed diagnosis (Merrill et al., 2010).
Disparities in melanoma incidence can be attributed to
disparities in socioeconomic status (SES). Although melanoma
incidence is generally associated with higher SES (Hemminki
et al., 2003), low SES has been correlated with advanced stage
of melanoma at diagnosis and worse survival (Roetzheim
et al., 2000; Ortiz et al., 2005; Zell et al., 2008). The
relationship between SES and melanoma epidemiology is
complex, mitigated by genetic risk, environmental exposure,
and prevention practices among populations of varying SES
strata and racial/ethnic backgrounds. In the United States, a
greater proportion of Hispanics and blacks are at lower SES
compared with NHW (DeNavas-Walt et al., 2012). Lower SES
is more strongly associated with thicker melanomas among
Hispanics than NHW in California (Pollitt et al., 2011). The
association between SES and melanoma outcome is further
confounded by insurance status as uninsured individuals have
more comorbidities and limited access to health care (Powell-
Griner et al., 1999). In addition, the uninsured or those
covered by Medicaid are more likely to be less educated,
unemployed, and less likely to be married (Halpern et al.,
2008).
Although low individual-level SES negatively impacts
health, individual-level SES data are rarely available in public
data sets. SES on a community level, referred to as ‘‘area-
based socioeconomic measure’’ or ‘‘ABSM’’, also influences
health at both the population and individual levels (Szreter
and Woolcock, 2004). ABSM provides important, quantitative
assessments of the social context in which an individual
resides and helps capture the capacity of individuals to
access and benefit from health resources (Shavers, 2007).
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For cancer, mounting evidence exists that ABSM is associated
with both incidence and mortality (Singh et al., 2003) and for
melanoma specifically, data from 44 central cancer registries
found a relationship between melanoma stage and aggregate
ABSM at county level (Singh et al., 2011). Smaller and
more homogenous geographic units such as census tracts
and block groups provide a more meaningful contextual
socioeconomic indication of linked cancer cases. Few
studies have utilized census tract or block group-level ABSM
to examine melanoma outcome (Pollitt et al., 2008, 2011;
Clarke et al., 2010), and they were limited by not including
Hispanics or only accounting for Medicaid as an insurance
variable. In addition, the majority of the studies examined
trends in California, where Hispanics are of mostly Mexican
origin (US Census Bureau, 2012), thus affecting
generalizability.
Another knowledge gap in melanoma disparity is identifica-
tion of local communities with higher burden of late-stage
melanoma. Although we previously have shown that late-
stage melanoma rates are unequally distributed by zip code in
Miami-Dade (Yin et al., 2011), this common method of
mapping disease rates, choropleth mapping (mapping ranges
of rates by geographic area, i.e., the Center for Disease
Control and Prevention state maps), does not allow for
quantitative risk assessment. As choropleth maps rely on
subjective mapping to assess risk, rates in sparsely populated
areas can be outlier rates or statistically insignificant, leading
to unwarranted alarm or inappropriate disregard (Boscoe
et al., 2003). In this study, we applied geospatial techniques
to more accurately identify and characterize communities
with excess rates of late-stage disease, which will allow
melanoma control efforts to be prioritized and better
targeted, particularly because the rate of late-stage disease is
a proxy for screening or access to medical care (Gregorio
et al., 2002; Abe et al., 2006; Henry et al., 2009).
Using spatial analysis, we aim to clarify how poverty,
insurance status, race, and Hispanic ethnicity impact mela-
noma stage at diagnosis and to develop a predictive model for
melanoma cases being diagnosed from geographic areas of
higher-than-expected incidence of late-stage melanoma. We
linked melanoma cases from the Florida Cancer Data System
(FCDS) to ABSM, specifically, percentage of persons living in
poverty by census tract, then used a geospatial technique,
cluster detection, to identify areas with a disproportionate
burden of late-stage melanoma incidence. We conducted
logistic regression to model individual-level insurance status,
race/ethnicity, and area-based poverty to predict clustering of
late-stage melanoma cases.
RESULTS
Distribution of melanoma cases
After excluding 3,175 cases without geocodes at the census
tract level, our study population comprises 43,385 geocoded
melanoma cases diagnosed in Florida from 1999 to 2008,
occurring among 38,527 NHW, 1,251 Hispanic whites, 229
blacks, and 3,378 patients with other/unknown race or
ethnicity (Table 1). Of these, 13,381 were melanoma in situ,
22,420 were at local stage, 2,783 at regional stage, 1,272 at
distant stage, and 3,529 were unstaged. In all, 59% of the
cases (25,625) were men. Patients insured by Medicare or
private insurance made up 46% and 44% of the cases,
respectively (Table 2). When melanoma cases were stratified
by stage at diagnosis, NHW had highest proportion of
melanoma diagnosed at local stage (Table 1). Both Hispanic
whites and blacks had disproportionately higher percentages
of distant stage melanoma compared with NHW (6% and 9%
vs. 3%, respectively, Po0.001). Late-stage melanoma data set
included regional, distant, and unknown stage cases.
Unknown stage cases often represent people not connected
with health care (e.g., diagnosed at or near time of death,
diagnosed but no work up or treatment), and have similar
5-year survival rates to that of regional stage melanoma (Wu
et al., 2011; Howlader et al., 2013).
Table 1. Distribution of geocoded melanoma cases by
stage and race/ethnicity, Florida, 1999–2008
N (% within population group)
Stage at
diagnosis
Non-Hispanic
whites
(n¼ 38,527)
Hispanic
whites
(n¼ 1,251)
Blacks
(n¼ 229)
Others
(n¼ 3,378)
In situ (n¼13,381) 11,191 (29) 299 (24) 41 (18) 1,850 (55)
Local (n¼22,420) 20,403 (53) 595 (47) 93 (41) 1,329 (39)
Regional (n¼2,783) 2,597 (7) 108 (9) 28 (12) 50 (1)
Distant (n¼ 1,272) 1,151 (3) 73 (6) 20 (9) 28 (1)
Unknown (n¼3,529) 3,185 (8) 176 (14) 47 (20) 121 (4)
N¼43,385; w2¼ 1,274.45; Po0.001.
Table 2. Demographic characteristics of geocoded
melanoma cases, Florida, 1999–2008
Variable Total (n¼ 43,385) Late stage (n¼ 7,584)
Sex
Male 25,625 (59%) 4,795 (63%)
Race/ethnicity
Non-Hispanic white 31,594 (96%) 6,933 (94%)
Hispanic white 1,251 (3%) 357 (5%)
Black 229 (1%) 95 (1%)
Insurance
Private 19,106 (46%) 2,768 (40%)
Medicaid 529 (1%) 198 (3%)
Medicare 20,160 (49%) 3,541 (51%)
None 1,272 (3%) 355 (5%)
Other1 177 (1%) 55 (1%)
Age (years) 63.7±16.3 64.7±16.5
Poverty (%)2 9.4±6.5 10.4±7.2
1Military or Indian insurance.
2Percentage of population living below the poverty line at the census tract
level.
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Cluster analysis was performed on 43,385 geocoded cases,
and multivariable logistic regression models based on the
results of spatial analysis were performed on 38,239 cases
after excluding 5,146 cases with incomplete insurance status,
age, sex, or race/ethnicity. Geographic clusters of higher-than-
expected incidence of late-stage melanoma, referred to as
‘‘high-risk clusters’’, were detected in the total population
(N¼ 38,239), men (N¼22,598), women (N¼15,641), NHW
(N¼ 36,851), NHW men (N¼ 21,885), NHW women
(N¼ 14,966), and Hispanic whites (N¼ 1,168). We did not
detect significant clusters among blacks, likely due to small
sample size (N¼220).
Hispanic ethnicity, ABSM, Medicaid, and Medicare coverage are
associated with high-risk clusters among the total population
Multivariable logistic regression analyses of cases living in
high-risk clusters in the total population found Hispanic
ethnicity to be a significant predictor: Hispanic whites overall
were 41%, Hispanic white men 42%, and Hispanic white
women nearly 22 times more likely to reside in areas with
higher-than-expected incidence of late-stage melanoma, com-
pared with NHW overall, NHW men, or women, respectively
(Po0.001; Table 3). Black women were also more likely to
live in high-risk clusters compared with NHW women (odds
ratio (OR) 3.09; 95% confidence interval (CI) 1.99–4.81,
Po0.001), however, blacks overall did not have increased
odds to live in high-risk clusters.
Area-based poverty also predicted excess late-stage diag-
nosis: as the percentage of persons living below poverty level
(within the neighborhood) increased by 1%, men were 3%
more likely, and women 7% more likely of living in high-risk
clusters (Po0.001). The overall effect was a 2% increase in
the odds for higher-than-expected rate of late-stage melanoma
for every 1% increase in poverty (Po0.001).
Compared with patients with private insurance, Medicaid
(OR 1.23; 95% CI 1.02–1.48, P¼ 0.027) and Medicare (OR
1.15; 95% CI 1.08–1.23, Po0.001) recipients were more
likely to live in areas with increased burden of late-stage
melanoma. However, the negative impact of Medicaid cover-
age was not statistical significant when analyses were stratified
by gender. On the other hand, Medicare coverage was
associated with lower odds for late-stage melanoma clustering
among women. Lack of insurance coverage was not a
statistically significant predictor for living in high-risk areas
for men or women.
ABSM, public health insurance, or lack of insurance are
associated with high-risk clusters among NHW
Neighborhood poverty predicted case-level clustering of late-
stage melanoma among NHW. For every 1% increase in the
percentage of persons living below poverty, NHW men were
5% more likely, and NHW women were 8% increase more
likely to live in a high-risk cluster (Po0.001; Table 4).
Compared with patients with private insurance, NHW with
Medicaid, Medicare, or no insurance were all more likely to
live in high-risk areas, with Medicaid recipients having
the highest odds (OR 1.58; 95% CI 1.25–2.01, P o0.001).
Uninsured NHW or those with Medicare coverage were 23%
more likely (P¼ 0.020), and 19% more likely (Po0.001),
respectively, to live in high-risk clusters. Stratified by gender,
NHW women with Medicaid were more likely to live in high-
risk clusters (OR 2.39; 95% CI 1.18–4.81, P ¼0.015). NHW
men with Medicare were 17% more likely compared with
NHW men with private insurance to live in high-risk areas
(P¼ 0.001).
ABSM, Medicaid coverage, or lack of insurance are associated
with high-risk clusters among Hispanic whites
Hispanic whites with melanoma diagnosed in high-risk
clusters tend to be from poor neighborhoods, similar to that
seen in NHW, but with even greater poverty. For every 1%
increase in poverty, a Hispanic white person is 2% more
likely to live in a high-risk cluster (P¼ 0.003; Table 5).
Hispanic whites receiving Medicaid were at least twice
more likely than those with private insurance to live in
high-risk clusters (P¼ 0.022) as were those without insurance
(OR 2.27; 95% CI: 1.30–3.97, P¼ 0.004). Medicare
coverage was not a significant predictor for Hispanic whites
to live in a high-risk cluster. Significant clusters were only
identified when Hispanic white men and women were
combined.
DISCUSSION
Through spatial analysis of geocoded melanoma cases diag-
nosed in Florida from 1999 to 2008, we examined the impact
of ABSM, insurance status, and Hispanic ethnicity on cluster-
ing of late-stage melanoma. Consistent with prior studies (Hu
et al., 2009; Wu et al., 2011), Hispanic whites and blacks had
disproportionately higher percentages of late-stage melanoma
at diagnosis compared with NHW. Melanomas within clusters
of higher-than-expected incidence of late-stage melanoma
tend to be from poor neighborhoods and areas with a high
proportion of Hispanic residents. Hispanic white women were
most likely to live in areas with excess burden of late-stage
melanoma. The impact of insurance status on clustering of
late-stage melanoma was more attenuated and varied among
populations.
Florida is a sentinel state for melanoma prevention
The population is a unique strength for the study as Florida is
one of the top three states where450% of total US Hispanics
reside (Ennis et al., 2011) and has high case counts of
melanoma (US Cancer Statistics Working Group, 2013).
Studying melanoma in Florida fills an important knowledge
gap as Hispanics in Florida are mostly of Cuban and Puerto
Rican origins, different from California or Texas where
Hispanics are predominantly Mexicans and Salvadorans
(Ennis et al., 2011). We previously reported on melanoma
disparity in Florida with delayed diagnosis (either regional or
distant stage) among Hispanic whites and blacks compared
with NHW (Hu et al., 2009). Melanoma incidence has
increased significantly among Hispanics in Florida,
particularly among Hispanic women at an annual increase
of 3.4% (P¼ 0.01) (Hu et al., 2009). With Hispanic popula-
tions rising nationally, especially in southern states (Ennis
et al., 2011) and the growing melanoma burden among
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Hispanics (Ries et al., 2005; Cockburn et al., 2006;
Rouhani et al., 2008; Pollitt et al., 2011), Florida is an
important benchmark state for evaluating melanoma
prevention efforts.
Hispanics are more likely to live in areas with excess burden of
late-stage melanoma
We found Hispanic ethnicity to be the strongest predictor for
cases to reside in areas at high risk of late-stage diagnoses,
Table 3. Characteristics and predictors of high-risk clusters of late-stage melanoma cases among the total population
All Male Female
Variable (n, %)
No–low risk1
(n¼27,236)
High risk
(n¼11,003) P-value
No–low risk
(n¼ 17,411)
High risk
(n¼5,187) P-value
No–low risk
(n¼ 14,483)
High risk
(n¼1,158) P-value
Sex 0.264
Male 16,047 (60%) 6,551 (60%)
Female 11,189 (40%) 4,452 (40%)
Race/ethnicity o0.001 o0.001 o0.001
Hispanic white 721 (3%) 447 (4%) 220 (2%) 195 (4%) 220 (1%) 315 (27%)
Black 150 (o1%) 70 (1%) 62 (0%) 18 (o1%) 113 (1%) 27 (2%)
Non-Hispanic
white
26,365 (97%) 10,486 (95%) 16,911 (97%) 4,974 (96%) 14,150 (98%) 816 (71%)
Insurance o0.001 0.200 o0.001
Medicaid 326 (1%) 186 (2%) 185 (1%) 69 (1%) 211 (2%) 47 (4%)
Medicare 13,411 (50%) 5,331 (48%) 9,286 (53%) 2,700 (52%) 6,351 (44%) 405 (35%)
None 777 (3%) 369 (3%) 491 (3%) 162 (3%) 427 (3%) 66 (6%)
Other 106 (o1%) 61 (1%) 95 (1%) 33 (1%) 38 (o1%) 1 (o1%)
Private 12,616 (46%) 5,056 (46%) 7,354 (42%) 2,223 (43%) 7,456 (51%) 639 (55%)
Age (years) 64.0±16.2 62.7±16.7 o0.001 65.6±15.2 65.2±15.5 0.171 61.0±17.4 60.0±18.5 0.097
Poverty (%)2 9.1±6.2 10.1±7.3 o0.001 3.9±3.2 4.2±3.1 o0.001 5.3±3.6 6.9±4.6 o0.001
OR 95% CI P-value OR 95% CI P-value OR 95% CI P-value
Age (per year) 0.99 (0.99–1.00) o0.001 1.00 (1.00–1.00) 0.889 1.01 (1.00–1.01) 0.003
Poverty (per 1%)3 1.02 (1.02–1.02) o0.001 1.03 (1.02–1.04) o0.001 1.07 (1.06–1.09) o0.001
Sex
Female Reference
Male 1.05 (1.01–1.10) 0.030
Race/ethnicity
Non-Hispanic
white
Reference
Hispanic white 1.41 (1.24–1.59) o0.001 1.42 (1.19–1.69) o0.001 21.52 (17.77–26.20) o0.001
Black 0.97 (0.73–1.30) 0.842 0.86 (0.51–1.46) 0.581 3.09 (1.99–4.81) o0.001
Insurance
Private Reference
Medicaid 1.23 (1.02–1.48) 0.027 1.14 (0.86–1.52) 0.354 1.24 (0.83–1.84) 0.296
Medicare 1.15 (1.08–1.23) o0.001 0.97 (0.89–1.05) 0.456 0.63 (0.53–0.76) o0.001
None 1.08 (0.95–1.23) 0.226 1.04 (0.87–1.26) 0.657 1.10 (0.80–1.51) 0.575
Other4 1.37 (1.00–1.88) 0.053 1.14 (0.76–1.69) 0.533 0.28 (0.04–2.18) 0.224
Abbreviations: CI, confidence interval; OR, odds ratio.
1Areas outside of the high-risk clusters.
2Percentage of population living below the poverty line at the census tract level.
3Per every 1% increase in percentage of population living below the poverty line at the census tract level.
4Military or Indian insurance.
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independent of poverty, insurance status, age, and gender.
This reiterates the critical need to address and reduce
melanoma disparity among US Hispanics. Hispanics are
diagnosed with more advanced stage melanoma and have
worse survival rates compared with NHW (Wu et al., 2011),
and melanoma incidence among US Hispanics has increased
at an annual rate of 2.9% (Po0.05), comparable to the 3.0%
annual increase among NHW (Ries et al., 2005). In California,
thicker melanomas (associated with worse prognosis) accoun-
ted for most of the increases among Hispanics (Cockburn
et al., 2006).
Delayed melanoma diagnosis among Hispanics can be
attributed to a multitude of factors. Poverty and insurance
status contributes to disparities in cancer burden among
minorities (American Cancer Society, 2013). In 2010, 41 in
4 Hispanics lived below the poverty line, compared with 1 in
10 NHW, and while 1of 3 Hispanics were uninsured only 1 in
10 NHW was uninsured (DeNavas-Walt et al., 2012). We
adjusted for the effects of community-level poverty and
individual insurance status but this did not mitigate the
impact of Hispanic ethnicity. Therefore, barriers unique to
Hispanic communities are important to consider. It has been
shown that Hispanics receive suboptimal screenings and have
lower knowledge and awareness of melanoma/skin cancer
risks. Less than one in six US Hispanic adults had full body
skin examination by physicians (40% less likely than NHW),
additionally, Hispanics are less likely to perform self-skin
exam than NHW (Andreeva and Cockburn, 2011). Less than
one in five Hispanic adults ever performed self-skin exams
(Coups et al., 2013), whereas one in three NHW adults to one
in two NHW adults report self-skin exams (Pipitone et al.,
2002; Hamidi et al., 2008). Patient and provider awareness,
Table 4. Characteristics and predictors of high-risk clusters of late-stage melanoma cases among non-Hispanic whites
All Male Female
Variable
No–low risk1
(n¼ 31,390)
High risk
(n¼ 5,461) P-value
No–low risk
(n¼17,795)
High risk
(n¼4,090) P-value
No–low risk
(n¼14,700)
High risk
(n¼266) P-value
Sex 0.030
Male 18,569 (59%) 3,316 (61%)
Female 12,821 (41%) 2,145 (39%)
Insurance o0.001 0.064 0.016
Medicaid 338 (1%) 92 (2%) 170 (1%) 50 (1%) 201 (1%) 9 (3%)
Medicare 15,284 (49%) 2,947 (54%) 9,452 (53%) 2,247 (55%) 6,402 (44%) 130 (49%)
None 851 (3%) 171 (3%) 488 (3%) 106 (3%) 421 (3%) 7 (3%)
Other 137 (o1%) 23 (o1%) 96 (1%) 27 (1%) 36 (o1%) 1 (o1%)
Private 14,780 (47%) 2,228 (41%) 7,589 (42%) 1,660 (40%) 7,640 (52%) 119 (45%)
Age (years) 63.5±16.4 65.1±16.0 o0.001 65.6±15.2 65.5±15.1 0.490 61.0±17.4 61.9±18.0 0.406
Poverty (%)2 7.3±5.1 9.1±5.9 o0.001 3.1±2.6 3.5±3.1 o0.001 4.4±3.2 5.6±2.8 o0.001
OR 95% CI P-value OR 95% CI P-value OR 95% CI P-value
Age (per year) 1.00 (1.00–1.01) 0.027 1.00 (0.99–1.00) 0.012 1.00 (0.99–1.01) 0.479
Poverty (per 1%)3 1.05 (1.05–1.06) o0.001 1.05 (1.04–1.06) o0.001 1.08 (1.05–1.10) o0.001
Sex
Female Reference
Male 1.05 (0.99–1.11) 0.1361
Insurance
Private Reference
Medicaid 1.58 (1.25–2.01) o0.001 1.26 (0.92–1.74) 0.156 2.39 (1.18–4.81) 0.015
Medicare 1.19 (1.09–1.28) o0.001 1.17 (1.07–1.29) 0.001 1.40 (0.99–1.97) 0.059
None 1.23 (1.03–1.46) 0.0197 0.94 (0.76- 1.17) 0.584 0.99 (0.46–2.14) 0.978
Other4 1.01 (0.65–1.59) 0.957 1.24 (0.80–1.91) 0.334 1.72 (0.23–12.68) 0.594
Abbreviations: CI, confidence interval; OR, odds ratio.
1Areas outside of the high-risk clusters.
2Percentage of population living below the poverty line at the census tract level.
3Per every 1% increase in percentage of population living below the poverty line at the census tract level.
4Military or Indian insurance.
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sociocultural beliefs, and acculturation likely influence the
delivery and utilization of screening practices in Hispanics.
For instance, we found Hispanic high school students have
lower skin cancer knowledge and awareness and were less
likely than their NHW peers to have heard of or performed
self-skin exams (Ma et al., 2007). Hispanic adults of greater
acculturation and higher SES were more likely to receive skin
cancer screening services (Coups et al., 2013). Given the
heterogeneity of Hispanic communities, we need to stratify at-
risk Hispanics by ethnic backgrounds, SES, and acculturation.
This study identified Hispanic women living in poorer
neighborhoods to be most likely to carry excessive burden
of advanced stage melanoma; therefore, it will be important to
design and implement outreach programs targeting this
population.
The overall higher proportion of late-stage melanoma
among Hispanics and their significantly higher odds to be
within clusters of late-stage melanoma compared with NHW
may reflect lack of linguistically or culturally appropriate
education and screening efforts (Saraiya et al., 2004) and
low provider awareness on unique features of melanoma in
Hispanics. For instance, melanoma in Hispanics most
commonly are found on trunk, lower limb, and hip (Wu
et al., 2011). Hispanics also have the highest incidence of
acral lentiginous melanoma compared with other groups
(Bradford et al., 2009; Wu et al., 2011), therefore melanoma
can be missed if an at-risk Hispanic patient is not screened
with full body skin examination with special attention to acral
areas. Finally, differences in biologic behavior of melanomas
may exist among racial and ethnic populations, which can
lead to more aggressive cancers and pose greater challenge to
early clinical detection in certain populations.
Advanced stage melanomas are clustered in poorer
neighborhoods
Melanomas from high poverty census tracts were more likely
to be within a cluster of higher-than-expected rate of late-stage
melanoma. This was consistent for the total study population,
NHW, and Hispanic whites. Studies of Surveillance, Epide-
miology, and End Results (SEER) data and California Cancer
Registry data found similar associations between ABSM and
melanoma thickness/stage (Pollitt et al., 2011; Singh et al.,
2011), underscoring the importance of social context in which
an individual resides when designing interventions. For
example, it is plausible that infrastructure characteristics
(such as lack of health clinics, hospitals, or public trans-
portation services) in an impoverished area impede access and
delivery of skin cancer screening services. Public education
campaigns on risks and signs of melanoma need to reach low-
income communities to reduce disparity.
The association between insurance status and high-risk clusters
varied among populations
Patients with private insurance were designated as the refer-
ence group for comparison with patients covered by Medi-
caid, Medicare, or without insurance. Medicaid coverage was
consistently associated with higher odds of cases residing in a
cluster of late-stage melanoma among the total population,
NHW, and Hispanic whites. This association does not
necessarily imply inadequate screening services or access
among Medicaid recipients, rather more likely disparities
among those uninsured, as retroactive enrollment in Medicaid
often occurs after a cancer diagnosis. In a linkage study of
melanoma patients from California Cancer Registry, people
newly enrolled (OR 13.6; 95% CI 4.43–41.98) or intermit-
tently enrolled (OR 2.77; 95% CI 1.28–5.99) in Medicaid
were more likely to have late-stage melanoma compared
with those not enrolled in Medicaid (Pollitt et al., 2008).
Interestingly, people continuously enrolled in Medicaid did
not have increased risk for late-stage melanoma (Pollitt et al.,
2008). The varying impact of Medicaid by enrollment history
Table 5. Characteristics and predictors of high-risk
clusters of late-stage melanoma cases among Hispanic
whites
All
Variable
No–low risk1
(n¼1,028)
High risk
(n¼ 140) P-value
Sex 0.701
Male 555 (54%) 78 (56%)
Female 473 (46%) 62 (44%)
Insurance 0.008
Medicaid 55 (6%) 14 (10%)
Medicare 363 (35%) 48 (34%)
None 84 (8%) 21 (16%)
Other 3 (o1%) 0 (0%)
Private 523 (51%) 57 (40%)
Age (years) 59.8±17.4 60.8±18.0 0.522
Poverty (%)2 12.1±10.4 15.2±9.9 0.001
OR 95% CI P-value
Age (per year) 1.01 (1.00–1.02) 0.272
Poverty (per 1%)3 1.02 (1.01–1.04) 0.003
Sex
Female Reference
Male 1.08 (0.75–1.55) 0.673
Insurance
Private Reference
Medicaid 2.16 (1.12–4.16) 0.022
Medicare 0.99 (0.62–1.60) 0.982
None 2.27 (1.30–3.97) 0.004
Other4
Abbreviations: CI, confidence interval; OR, odds ratio.
1Areas outside of the high-risk clusters.
2Percentage of population living below the poverty line at the census tract
level.
3Per every 1% increase in percentage of population living below the
poverty line at the census tract level.
4Military or Indian insurance, too few to analyze.
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may explain why having Medicaid was at best a modest risk
factor for living in high-risk clusters in this study, as Medicaid
enrollment history was not studied.
Medicare coverage was also a predictor for higher burden of
late-stage melanoma among the total population and NHW,
consistent with the previously shown higher risk of Medicare
enrollees for late-stage melanoma (risk ratio 1.13, 95% CI
1.01–1.26) compared with those with private insurance (Ward
et al., 2010). The same study found patients with Medicare
Advantage or with supplemental programs were not at higher
risk for late-stage melanoma (Ward et al., 2010). Examination
of Medicare-linked SEER melanoma cases also demonstrated
that melanoma stage at diagnosis differed by Medicare health
maintenance organizations or fee-for-service among different
populations (Kirsner et al., 2005; Rouhani et al., 2010) and
likely explains why we found inconsistent associations between
Medicare coverage and clustering of late-stage melanoma.
Uninsured people are typically at higher risk for advanced
stage cancers including melanoma (Roetzheim et al., 1999;
Halpern et al., 2008). In this study, uninsured NHW and
Hispanics were more likely to live in high-risk clusters. The
higher odds for late-stage melanoma among Hispanics without
insurance likely reflects the greater proportion of undocu-
mented immigrants or migrant laborers among Hispanics, who
are also more likely to be uninsured or less willing to utilize
public health services (Berk et al., 2000). Interventions target-
ing these at-risk populations will require greater sociocultural
sensitivities of health-care providers and implementation of
appropriate community outreach programs.
Study limitations
There are several limitations inherent to cancer registry data
analyses. As an ecological, cross-sectional study with potential
for ecologic fallacy and lacking temporality, we are not able to
infer causal associations between poverty and delayed mela-
noma diagnoses. However, the contextual influence of neigh-
borhood poverty and individual-level insurance status is
associated with cancer burden, so the risk of ecologic fallacy
is of diminished concern.
Our analysis did not account for spatial autocorrelation,
which occurs when cases that are geographically closer have
more similar characteristics than cases that are more geogra-
phically distant, e.g., poverty rates or levels of Hispanic
segregation. If there was spatial autocorrelation among vari-
ables, it is possible the standard error of the estimates were
underestimated. Future analysis would benefit from applying
other geospatial techniques, like spatial regression, which
accounts for spatial correlation between variables.
Under-reporting of melanoma cases to state cancer regis-
tries, especially of thin or early-stage melanomas that are often
treated in ambulatory clinics may occur (Cockburn et al.,
2008; Cartee et al., 2011), however, the cluster analyses were
run on late-stage melanomas, which more likely required
hospital admissions. Similarly, bias from over-diagnosing of
melanoma is possible but likely minimal as we focused on the
relative risk of late-stage melanomas at diagnosis. We also had
modest missing data rates: 3,175 (6.8%) of total cases were
not geocoded. However, the differences between ungeocoded
and geocoded cases in terms of Hispanic ethnicity or insurance
status were small and not meaningful. An additional 5,146
cases (11%) were excluded from logistic regression modeling
because of missing insurance, age, sex, or race/ethnicity. The
distribution of missing data in the clustering modeling was
similar to that of final analytic sample across all variables and
does not seem to have an effect on our findings except for the
loss of power due to the smaller number of cases to analyze.
Finally, 3,529 cases (8%) were unstaged, which is comparable
to percentages of unstaged or unknown stages in SEER data or
state cancer registry data (Singh et al., 2011; Wu et al., 2011).
We did not conduct Hispanic subgroup analysis and it is
possible that clustering of late-stage melanoma varies as
substantial differences exist in sociodemographic characteris-
tics, acculturation, and health outcomes among Hispanic
populations in the United States (Hajat et al., 2000). A
follow-up study evaluating Hispanic subgroups using a
different spatial model may provide further insight into this
area.
Finally, patient-level poverty was not used to assess the
impact of SES on melanoma stage; rather, we utilized area-
based poverty. Studies have shown that associations between
SES and health outcomes have been similar when SES is
measured at either the individual or the community level
(Hofer et al., 1998) and the utility of ABSM in evaluating
melanoma incidence and stage has been validated (Pollitt
et al., 2011; Singh et al., 2011). Furthermore, incorporating
ABSM in a predictive model of melanoma stage allows for
opportunity to prospectively identify at risk communities. The
lack of individual-level poverty status is further ameliorated by
including individual-level insurance status in the analysis.
Conclusion
We found melanomas diagnosed in Hispanic whites are much
more likely to be from areas with higher-than-expected
incidence of late-stage melanoma compared with NHW.
Within Hispanic communities, we identified neighborhood
poverty, Medicaid coverage, or lack of insurance as additional
predictors for cases living in clusters of late-stage melanoma.
Barriers unique to Hispanic communities such as language,
immigration status, acculturation, knowledge, and behavior
relevant to melanoma prevention and diagnosis need to be
addressed and overcome. More studies are needed to account
for heterogeneity of Hispanic communities and to clarify the
relevance of sociocultural values and tumor biology on
melanoma outcome in Hispanics.
MATERIALS AND METHODS
Cancer data source
This study received approval from Florida Department of Health IRB
(Protocol H10118) and was conducted according to the Declaration
of Helsinki Principles. De-identified primary cutaneous melanoma
cases in Florida residents (International Classification of Disease, third
edition (ICD-O-3), site codes C440–C449 and histological codes
8720–8790) between 1 January 1999 and 31 December 2008 were
selected from FCDS. FCDS is a high-quality state cancer registry and
has met or exceeded the North American Association of Central
Cancer Registries (NAACCR) standards of quality, timeliness, and
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completeness since 1995 (Huang et al., 2007). Melanoma stage at
diagnosis was coded according to SEER summary staging guidelines,
e.g., in situ, local (skin only), regional (direct extension and/or nodal
involvement), and distant (distant sites or nodes involved). Late stage
was defined as regional, distant, or unknown stage at diagnosis. Cases
with unknown age, unknown census tract, or geocoded above census
tract were excluded.
Race/ethnicity definition
In FCDS, Hispanic ethnicity is identified from NAACCR item number
190, Spanish surname, or origin (Jean-Baptiste and Gebhard, 2002).
Hispanic ethnicity is assigned from ethnicity recorded in medical
records or death certificates, or imputed based on surname or maiden
name using standard algorithms (Jean-Baptiste and Gebhard, 2002).
Race and ethnicity variables were combined to create three mutually
exclusive racial/ethnic groups: NHW, Hispanic whites, and blacks.
Area-based socioeconomic measure
The variable, percentage of persons living below the federally
designated poverty level at census tract, was selected as the ABSM
in this study and obtained from the 2006 to 2010 American
Community Survey (ACS). ACS is an ongoing statistical survey that
has replaced the US Census long form and is used to describe the
sociodemographic characteristics of a community. The poverty
threshold is uniform throughout the country and is not adjusted for
local or regional differences in cost of living. We selected census
tract-level poverty since census tract is the lowest level of geography
that ACS only releases data at the level of detail needed for our
analysis. Census tracts, with an average size of about 4,000 people,
are intended to represent rather homogenous neighborhoods with
respect to population characteristics, economic status, and living
conditions.
Insurance status
The patient’s insurance status at the time of diagnosis in the FCDS file
was recoded from 17 different values into five mutually exclusive
categories: uninsured, private, Medicare, Medicaid, and others
(military or Indian insurance).
Spatial analysis
Melanoma cases were analyzed at the census tract-level using the
spatial scan statistic in the NCI developed software, SaTScan version
9.1.1 (Boston, MA) to identify clusters of late-stage melanoma
incidence. Incidence rates were stratified by race and ethnicity
(NHW, Hispanic whites, and blacks) and were sex- and age-adjusted
using the indirect method to enable area-based comparisons. We
used US Census 2000 population data to calculate rates for cases
diagnosed in 1999–2004 and the aggregated 2005–2009 ACS
population estimates for cases diagnosed in 2005–2008. We used
SaTScan’s spatial scan, a cluster detection method commonly used in
public health (Chen et al., 2008), to test if the geographic distribution
of late-stage melanoma rates is statistically random. SaTScan imposes
nearly limitless scanning windows over the study area that vary in
size (the smallest single census tract, the largest aggregation of census
tracts containing up to 20% of the Florida population), and the
window with the highest maximum likelihood is assigned a P-value,
which is adjusted for multiple testing (Kulldorff, 1999). The selection
of a maximum cluster size of 20% of the population of Florida
represents a replicable standard that was used for a series of cancer
cluster analyses that generally resulted in cluster sizes manageable by
local public health agencies. To be considered a cluster for the
multivariable model, there must be a minimum of five cases per
geographic cluster with Pp0.10 to ensure public health significance.
The choice of a larger P-value for statistical significance was based
on a priori analysis, which indicated some of the analysis was
underpowered.
Regression analysis
Demographic characteristics (age, sex, and race/ethnicity), area-based
poverty level, insurance status, and stage at diagnosis were evaluated
and compared using T-tests and w2 statistics. Multivariable logistic
regression was conducted at the individual level to describe the
relationship of area-based poverty, insurance status, race/ethnicity
with cases residing in clusters of late-stage melanoma. The dependent
variable was whether a melanoma case is diagnosed in an area with
higher-than-expected incidence of late-stage melanoma, as identified
by cluster detection. Significance was defined as Po0.05.
CONFLICT OF INTEREST
The authors state no conflict of interest.
ACKNOWLEDGMENTS
We acknowledge the Florida Cancer Data System (FCDS). The Florida cancer
incidence data used in this report were collected by the FCDS under contract
with the Florida Department of Health (FDOH). The views expressed herein
are solely those of the authors and do not necessarily reflects those of the FCDS
or FDOH. This study is funded by the Dermatology Foundation Career
Development Award in Health Care Policy (to SH).
REFERENCES
Abe T, Martin IB, Roche LM (2006) Clusters of census tracts with high
proportions of men with distant-stage prostate cancer incidence in New
Jersey, 1995 to 1999. Am J Prev Med 30:S60–6
American Cancer Society (2013) Cancer Facts & Figures 2013. American
Cancer Society: Atlanta, GA
Andreeva VA, Cockburn MG (2011) Cutaneous melanoma and other skin
cancer screening among Hispanics in the United States: a review of the
evidence, disparities, and need for expanding the intervention and
research agendas. Arch Dermatol 147:743–5
Bellows CF, Belafsky P, Fortgang IS et al. (2001) Melanoma in African-
Americans: trends in biological behavior and clinical characteristics over
two decades. J Surg Oncol 78:10–6
Berk ML, Schur CL, Chavez LR et al. (2000) Health care use among
undocumented Latino immigrants. Health Aff (Millwood) 19:51–64
Boscoe FP, McLaughlin C, Schymura MJ et al. (2003) Visualization of the
spatial scan statistic using nested circles. Health Place 9:273–7
Bradford PT, Goldstein AM, McMaster ML et al. (2009) Acral lentiginous
melanoma: incidence and survival patterns in the United States, 1986-
2005. Arch Dermatol 145:427–34
Cartee TV, Kini SP, Chen SC (2011) Melanoma reporting to central cancer
registries by US dermatologists: an analysis of the persistent knowledge
and practice gap. J Am Acad Dermatol 65:S124–32
Chen J, Roth RE, Naito AT et al. (2008) Geovisual analytics to enhance spatial
scan statistic interpretation: an analysis of U.S. cervical cancer mortality.
Int J Health Geogr 7:57
Clarke CA, Moy LM, Swetter SM et al. (2010) Interaction of area-level
socioeconomic status and UV radiation on melanoma occurrence in
California. Cancer Epidemiol Biomarkers Prev 19:2727–33
Cockburn MG, Swetter SM, Peng D et al. (2008) Melanoma underreporting:
why does it happen, how big is the problem, and how do we fix it? J Am
Acad Dermatol 59:1081–5
S Hu et al.
Predictors of Late-Stage Melanoma
944 Journal of Investigative Dermatology (2014), Volume 134
Cockburn MG, Zadnick J, Deapen D (2006) Developing epidemic of
melanoma in the Hispanic population of California. Cancer 106:1162–8
Coups EJ, Stapleton JL, Hudson SV et al. (2013) Skin cancer surveillance
behaviors among US Hispanic adults. J Am Acad Dermatol 68:576–84
DeNavas-Walt C, Proctor B, Smith JC (2012) Current Population Reports, P60-
243, Income, poverty, and health insurance coverage in the Unitied
States: 2011. U.S. Census Bureau ohttp://www.census.gov/prod/
2012pubs/p60-243.pdf4, (accessed 20 July 2013)
Dennis LK (1999) Analysis of the melanoma epidemic, both apparent and real:
data from the 1973 through 1994 surveillance, epidemiology, and end
results program registry. Arch Dermatol 135:275–80
Ennis SR, Rios-Vargars M, Albert NG (2011) The Hispanic Population: 2010
ohttp://www.census.gov/prod/cen2010/briefs/c2010br-04.pdf4,
(accessed 20 July 2013)
Gregorio DI, Kulldorff M, Barry L et al. (2002) Geographic differences in
invasive and in situ breast cancer incidence according to precise
geographic coordinates, Connecticut, 1991-95. Int J Cancer 100:194–8
Hajat A, Lucas JB, Kington R (2000) Health outcomes among Hispanic
subgroups: data from the National Health Interview Survey, 1992-95.
Adv Data 1–14
Halpern MT, Ward EM, Pavluck AL et al. (2008) Association of insurance status
and ethnicity with cancer stage at diagnosis for 12 cancer sites: a
retrospective analysis. Lancet Oncol 9:222–31
Hamidi R, Cockburn MG, Peng DH (2008) Prevalence and predictors of skin
self-examination: prospects for melanoma prevention and early detection.
Int J Dermatol 47:993–1003
Hemminki K, Zhang H, Czene K (2003) Socioeconomic factors in cancer in
Sweden. Int J Cancer 105:692–700
Henry KA, Sherman R, Roche LM (2009) Colorectal cancer stage at diagnosis
and area socioeconomic characteristics in New Jersey. Health Place
15:505–13
Hofer TP, Wolfe RA, Tedeschi PJ et al. (1998) Use of community versus
individual socioeconomic data in predicting variation in hospital use.
Health Serv Res 33:243–59
Howlader N, Noone AM, Krapcho M et al. (2013) SEER Cancer Statistics
Review, 1975-2010. National Cancer Institute: Bethesda, MD
Hu S, Parmet Y, Allen G et al. (2009) Disparity in melanoma: a trend analysis
of melanoma incidence and stage at diagnosis among whites, Hispanics,
and blacks in Florida. Arch Dermatol 145:1369–74
Huang Y, Hylton T, Fan Z et al. (2007) Florida Annual Cancer Report: 2003
Incidence and Mortality. Florida Department of Health: Tallahassee, FL
Jean-Baptiste R, Gebhard IK (2002) Series IV: Cancer Case Ascertainment.
Procedure Guidelines for Cancer Registries. North American Association
of Central Cancer Registries: Springfield, IL
Kirsner RS, Wilkinson JD, Ma F et al. (2005) The association of Medicare health
care delivery systems with stage at diagnosis and survival for patients with
melanoma. Arch Dermatol 141:753–7
Kulldorff M (1999) Geographic information systems (GIS) and community
health: some statistical issues. J Public Health Manag Pract 5:100–6
Ma F, Collado-Mesa F, Hu S et al. (2007) Skin cancer awareness and sun
protection behaviors in white Hispanic and white non-Hispanic high
school students in Miami, Florida. Arch Dermatol 143:983–8
Merrill RM, Pace ND, Elison AN (2010) Cutaneous malignant melanoma
among white Hispanics and non-Hispanics in the United States. Ethn Dis
20:353–8
Ortiz CA, Goodwin JS, Freeman JL (2005) The effect of socioeconomic factors
on incidence, stage at diagnosis and survival of cutaneous melanoma.
Med Sci Monit 11:RA163–72
Pipitone M, Robinson JK, Camara C et al. (2002) Skin cancer awareness in
suburban employees: a Hispanic perspective. J Am Acad Dermatol
47:118–23
Pollitt RA, Clarke CA, Shema SJ et al. (2008) California Medicaid enrollment
and melanoma stage at diagnosis: a population-based study. Am J Prev
Med 35:7–13
Pollitt RA, Clarke CA, Swetter SM et al. (2011) The expanding melanoma
burden in California hispanics: Importance of socioeconomic distribution,
histologic subtype, and anatomic location. Cancer 117:152–61
Powell-Griner E, Bolen J, Bland S (1999) Health care coverage and use of
preventive services among the near elderly in the United States. Am J
Public Health 89:882–6
Ries LAG, Eisner MP, Kosary CL et al. (2005) SEER Cancer Statistics Review,
1975-2002. National Cancer Institute: Bethesda, MD
Roetzheim RG, Gonzalez EC, Ferrante JM et al. (2000) Effects of health
insurance and race on breast carcinoma treatments and outcomes. Cancer
89:2202–13
Roetzheim RG, Pal N, Tennant C et al. (1999) Effects of health insurance and
race on early detection of cancer. J Natl Cancer Inst 91:1409–15
Rouhani P, Arheart KL, Kirsner RS (2010) Differences in melanoma
outcomes among Hispanic Medicare enrollees. J Am Acad Dermatol
62:768–76
Rouhani P, Hu S, Kirsner RS (2008) Melanoma in Hispanic and black
Americans. Cancer Control 15:248–53
Saraiya M, Hall HI, Thompson T et al. (2004) Skin cancer screening among
U.S. adults from 1992, 1998, and 2000 National Health Interview
Surveys. Prev Med 39:308–14
Shavers VL (2007) Measurement of socioeconomic status in health disparities
research. J Natl Med Assoc 99:1013–23
Singh GM, BA, Hankey BF, Edwards BK (2003) Area Socioeconomic Variations
in U.S. Cancer Incidence, Mortality, Stage, Treatment, and Survival,
1975–1999. National Cancer Institute: Bethesda, MD, Report no. NIH
Publication No. 03-5417
Singh SD, Ajani UA, Johnson CJ et al. (2011) Association of cutaneous
melanoma incidence with area-based socioeconomic indicators-United
States, 2004-2006. J Am Acad Dermatol 65:S58–68
Szreter S, Woolcock M (2004) Health by association? Social capital, social
theory, and the political economy of public health. Int J Epidemiol
33:650–67
US Cancer Statistics Working Group (2013) United States cancer statistics:
1999-2009 incidence and mortality web-based report. U.S. Department
of Health and Human Services, Centers for Disease Control and Preven-
tion and National Cancer Institute ohttp://apps.nccd.cdc.gov/uscs/4,
(accessed 10 July 2013)
US Census Bureau (2012) Table 33. Regional distribution of the Hispanic
population by sex and region: 2011ohttp://www.census.gov/population/
hispanic/data/2011.html4, (accessed 20 July 2013)
Ward EM, Fedewa SA, Cokkinides V et al. (2010) The association of insurance
and stage at diagnosis among patients aged 55 to 74 years in the national
cancer database. Cancer J 16:614–21
Wu XC, Eide MJ, King J et al. (2011) Racial and ethnic variations in incidence
and survival of cutaneous melanoma in the United States, 1999-2006.
J Am Acad Dermatol 65:S26–37
Yin N, Parker DF, Hu S et al. (2011) Geographic distribution of melanoma in
Miami-Dade County, Florida: online first. Arch Dermatol 147:617–8
Zell JA, Cinar P, Mobasher M et al. (2008) Survival for patients with invasive
cutaneous melanoma among ethnic groups: the effects of socioeconomic
status and treatment. J Clin Oncol 26:66–75
S Hu et al.
Predictors of Late-Stage Melanoma
www.jidonline.org 945
